We are live on ! Find out more
JIR

James Investment Research Portfolio holdings

AUM $984M
1-Year Est. Return 36.03%
This Fund
S&P 500
This Quarter Est. Return
+4.2%
1 Year Est. Return
+36.03%
3 Year Est. Return
+106.79%
5 Year Est. Return
+132.49%
10 Year Est. Return
+460.95%
AUM
$2.44B
AUM Growth
-$176M
Cap. Flow
-$230M
Cap. Flow %
-9.43%
Top 10 Hldgs %
17.23%
Holding
896
New
110
Increased
195
Reduced
318
Closed
113

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.63%
2 Industrials 13.29%
3 Technology 12.16%
4 Financials 11.97%
5 Materials 6.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STLD icon
201
Steel Dynamics
STLD
$33.8B
$2.44M 0.1%
53,890
+8,255
+18% +$380K
VRS
202
DELISTED
Verso Corporation
VRS
$2.43M 0.1%
+72,200
New +$1.89M
MSGN
203
DELISTED
MSG Networks Inc.
MSGN
$2.43M 0.1%
+94,095
New +$2.26M
ESRX
204
DELISTED
Express Scripts Holding Company
ESRX
$2.42M 0.1%
25,461
-6,010
-19% -$512K
GVI icon
205
iShares Intermediate Government/Credit Bond ETF
GVI
$3.82B
$2.42M 0.1%
22,528
-773
-3% -$83.2K
GAP
206
The Gap Inc
GAP
$7.61B
$2.41M 0.1%
83,389
-52,592
-39% -$1.58M
PHM icon
207
Pultegroup
PHM
$24.8B
$2.4M 0.1%
96,853
+5,356
+6% +$152K
ANF icon
208
Abercrombie & Fitch
ANF
$6.56B
$2.39M 0.1%
113,345
+42,040
+59% +$1.02M
WU icon
209
Western Union
WU
$2.26B
$2.39M 0.1%
125,298
+10,128
+9% +$197K
CALY
210
Callaway Golf Company
CALY
$2.81B
$2.38M 0.1%
98,140
-13,405
-12% -$288K
TOWR
211
DELISTED
Tower International, Inc.
TOWR
$2.38M 0.1%
78,775
+1,875
+2% +$60.9K
UTHR icon
212
United Therapeutics
UTHR
$22.2B
$2.38M 0.1%
18,630
-2,797
-13% -$346K
COF icon
213
Capital One
COF
$133B
$2.38M 0.1%
25,060
-860
-3% -$83.7K
KMT icon
214
Kennametal
KMT
$2.29B
$2.38M 0.1%
54,605
+50,955
+1,396% +$2.02M
NOG icon
215
Northern Oil and Gas
NOG
$2.77B
$2.38M 0.1%
+59,476
New +$2.01M
MIK
216
DELISTED
Michaels Stores, Inc
MIK
$2.38M 0.1%
146,325
+114,330
+357% +$2.18M
VVX icon
217
V2X
VVX
$2.44B
$2.36M 0.1%
75,630
+1,705
+2% +$55K
WCC
218
WESCO International
WCC
$16.9B
$2.36M 0.1%
38,350
+34,390
+868% +$2.06M
DAR icon
219
Darling Ingredients
DAR
$9.86B
$2.35M 0.1%
+121,550
New +$2.4M
MATX icon
220
Matsons
MATX
$6.63B
$2.34M 0.1%
59,070
-1,995
-3% -$73.9K
HUM icon
221
Humana
HUM
$47B
$2.33M 0.1%
6,893
-2,545
-27% -$827K
SCG
222
DELISTED
Scana
SCG
$2.33M 0.1%
+59,900
New +$2.3M
DXC icon
223
DXC Technology
DXC
$1.69B
$2.33M 0.1%
24,885
-25,910
-51% -$2.29M
QEP
224
DELISTED
QEP RESOURCES, INC.
QEP
$2.33M 0.1%
205,605
+30,100
+17% +$325K
HCA icon
225
HCA Healthcare
HCA
$92.5B
$2.32M 0.1%
16,655
-4,170
-20% -$519K

Similar funds

James Investment Research's Q3 2018 Portfolio in Review

As of Q3 2018, James Investment Research held 896 positions worth $2.44B, down 6.7% from $2.61B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

James Investment Research withdrew a net $230M in Q3 2018, closing 113 positions and reducing 318 holdings. Its most notable exit was World Wrestling Entertainment, an estimated $3.65M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 15% a quarter earlier, followed by Industrials and Technology.

Against the trend, James Investment Research opened a new position in Acorda Therapeutics worth $2.48M.

  • James Investment Research's largest Q3 2018 buy was Acorda Therapeutics: 1,051 shares worth $2.48M.
  • James Investment Research added most to iShares 0-1 Year Treasury Bond ETF in Q3 2018, an estimated $11M increase.
  • James Investment Research's biggest Q3 2018 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $29.1M.
  • James Investment Research fully exited World Wrestling Entertainment in Q3 2018, selling an estimated $3.65M.
  • James Investment Research's ten largest holdings make up 17% of its $2.44B portfolio in Q3 2018.
  • James Investment Research opened 110 new positions and closed 113 in Q3 2018.
  • James Investment Research's portfolio value fell 6.7% quarter-over-quarter to $2.44B.

Based on James Investment Research's 13F filing for Q3 2018, filed 26 Oct 2018.